Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I know, I tried to figure that out, not the best speaker, I honestly have no idea. I just want some good news for a change.
Peter Hoang
You know absolutely. With respect to the pancreatic trial, the update for ASCO, the abstracts will become live on Wednesday at 5 PM Eastern Time. So we’ll look forward to providing more data you know, so you know after the object around in the course, when the presentation is actually given at the ASCO Conference.
Hi Phantom, I'm just trying to be clear on this Aspire/dilution matter. I had answered GoIrish1776 that "hopefully they can get needed cash from the Aspire deal without much killing dilution."
Am I correct in my understanding (and please tell me if I am wrong) that the Aspire deal is not the "normal dilution" and won't be as bad as normal as far as dilution for this reason.
In a "normal" deal, it goes like this: a stock price is let's say $10, the company will make a deal to sell shares at $8, so instantly the stock price will drop to around the $8 mark of the deal.
BUT in the Aspire deal, because Marker sets the price, and that price will be set at the current price or an aggregate of the previous 5 days (or something like that), it would be more like, MRKR's price will be let's say $5, they will make a deal to sell additional shares for right at about that same $5 price, so YES, there will be dilution as far as additional shares be added, but am I correct in saying that there will NOT be that dramatic decrease in share price since the deal would be made at or very near whatever the existing stock price is at that time, so we will not be getting killed as we would in a "normal" additional capital deal?
Also, there will be NO warrants with the Aspire deal.
Thank You
Just two comments. I would certainly expect some kind of good news within the next 12 month timeframe, and hopefully they can get needed cash from the Aspire deal without much killing dilution.
Looks like bad start to today. We'll see what happens Wednesday. ????
I know from past posts that you are deeper in MRKR than I am by like 30,000 shares (which sucks for both of us right now), but more in common. I too own JNCE and AVXL, sold SLS like 2 years ago, looked at SRNE several times over the last few years but never bought it. Never considered FATE. Screwed up by not buying FTSV. A recent screw up was looked at APTX a couple months ago when insider bought a bunch, I didn't buy it, I should have.
Concerning MRKR: me, you, Phantom, and everybody else is pissed about it right now.
I read this on stock twits today: "difference between picking the wrong company and being to early on the right one, doesn't look that different for quite a while."
I know that's true because I was in the same MRKR situation in the past with ALNY, ARWR, and MRTX, now worth about 20 billion combined.
Hang in there, what choice do we all have other than sell for a big loss.
You know what, it's my own fault for getting in this deep. I got nobody to blame other than myself. I just kept believing more, so I just kept buying more.
I refuse, I will not sell at a current 66% loss. Long term win, lose or die, I will ride this till the end.
But you can bet your a$$, I will buy no more shares.
Thanks Phantom, The reagent delay is probably covid related and I don't want to sound ethnocentric but I just hope this reagent is not coming from China. I wouldn't trust it to use even if they did issue a certificate of compliance or whatever it's called.
Can one of our science knowledgeable posters explain what exactly the reagent problem is?
I get the original reagent problem was no needed certificates (which you would think management should of known about before proceeding).
I get that Covid-19 is slowing the trial (along with other biotechs I own).
What is the reagent problem NOW?
Do these reagents come from China?
Didn't we hire a couple people who were supposed to take care of these things as we move forward because that is what their expertise were?
In other words, WTF is going on?
I have not yet joined the Peter bashing but seriously, WTF, screw up after screw up, this went wrong after that went wrong.
This went from: we have a cure for cancer … to: welcome to the clown show.
I'm almost too scared to listen. I just hope there is some good news for all of us who have been holders for MANY YEARS.
their website says 877-407-8913
The Dingo ate it's missing eye.
Yep, another week gone by … another nothing. I don't have much hope until trial news comes out. Other than a buy out/partnering (which there is no reason for until news), I don't see any reason for a large up in price.
HOPE I'M WRONG.
You know it's been about a year since this downhill price disaster started to happen. This is just getting real old. I hope some good data presents itself soon.
Cam Birge Appointed Interim CEO
Strategic Review Initiated
Financial Results Filed
Toronto, Ontario--(Newsfile Corp. - April 29, 2020) - Mojave Jane (CSE: JANE) (OTCQB: HHPHF) (FSE: OHCN) today announced that, effective immediately, Mr. Cam Birge, current Chairman of the Board, will replace Gary Latham as CEO on an interim basis. Mr. Latham has also resigned from the Company's Board of Directors. The Company also announced it has filed its financial results for the quarter ended February 29, 2020 on SEDAR. Additionally, the Mojave Jane Board of Directors announced it is initiating a strategic review.
Chairman of the Board and Interim CEO Cam Birge comments:
"We have come to a point where the Company is faced with a number of critical decisions. The extreme correction in the cannabis sector followed by the impact from the COVID-19 pandemic has made obtaining the financing required to execute on various initiatives impossible. Consequently, there have been drastic changes to the way the Company is run, as well as the need to suspend or terminate certain initiatives such as the intended acquisition of Pacific Crest 4 (Adelanto), in order to preserve shareholder value and continue as a going concern. We are currently holding a strategic review of our assets and liabilities, and are developing our go forward plan. The success of this plan is dependent upon successful negotiations with previous partners and creditors, which are underway. At this point, no guarantees can be made as to the outcome of this process."
What happened to … follow the money?
or was it just Forty Seven and Jounce?
https://www.marketwatch.com/story/how-to-invest-in-biotech-stocks-like-a-nobel-prize-winner-2019-10-24
I voted yesterday in 3 separate TDA accounts.
I KNOW, kind of hard to get that excited with MRKR price still well below
$6/$7.
Even with this up in price, this will look laughably cheap when Gilead makes their offer.
"if they had another CR in PC I bet they would have gotten more than a poster presentation at ASCO."
Unfortunately, I was thinking that myself. I guess we shall see soon.
Breast cancer info (TACTIC): https://clinicaltrials.gov/ct2/show/NCT03093350
OK, great news so far, now let's have some positive news on breast cancer, and then some good news on pancreatic cancer, and then let's get past $10 a share where we belong.
I HOPE YOU ARE 100% CORRECT.
"The science posters left more than a year ago. The investigators of company responses or a lack of left six+ months ago."
I think it's due to a combination of being embarrassed about being wrong and being pissed off over loss of funds.
"70,000 shares at an average of $8.53."
Oh My God, I thought I was the only nut that deep in with 42K shares @ $6.90, only had 29K shares when the crash started. Every time it went down I said "how much more can it go down, not much?", so I bought more ... and more ... and more.
Hi Eagle, The only 3 thoughts that I have are … hope … wait … & faith.
I think somewhere in the middle. If MRKR's market cap is 90 million, then (taking in to consideration that the price would go up during a buying spree), then 60 million would buy Half the company. BB have 20 Billion, so for 1/2 of 1 % of their money they would own 1/2 of MRKR. And if BB is wrong, what is it to them? A needed tax deduction.
I think you make many valid points. Your last point "It feels very much to me like the first year of the Dot Com crash." Yes, it does. You know who the rich people are now? Those that bought in the first year of the Dot Com crash.
I heard many decades ago, "You make most of your money in a bear market, you just don't realize it at the time."
AntiMarv, Here is my problem … and I'm going to tie something else in here that I have said before.
You said "all I know is our MultiTaa treatment works for lymphoma, pancreatic cancer , AML and I would imagine sarcoma, and breast cancer."
For the most part I believe that to be true AND I don't think you, me, and a few people on this board are not the only ones who believe that.
Next you said "The only reason Mrkr is not at least $10 right now is due to the 5 million shares shorted by large hedge funds."
Two months ago I would say that is 100% true, now it may be about 90% true.
Which leads me to my problem.
IF someone … let's say Baker Brothers, who I would assume believes in MRKR like we do … IF they believed …. with their money … WHY don't they come in at these prices with a LARGE additional position …. BECAUSE … IF they did that, they would blow 5 million shorts right out of the water, and we would be at $10.
Baker buys at 2, then 3, then 4, then 5 …. THEN all the shorts dump and force it to 10.
YES, I know, as soon as it get's to $10, then ALL the shorts will come back in and drop it back down to $7 or $8.
FINE, it beats the hell out of $2, and it's still well above Bakers average price.
Hi, I have a question. You said "The company already knows what the results are and will be sharing this information in the 3rd quarter this year."
If we did have a second complete remission, is there some law or something that would stop them from just putting out a press release?
GEEZ, as much as the price has tanked, just tell us, the sooner the better.
"are the majority of these million shares traded because of a mistake?!"
As crazy as it would seem, yes I believe it's due to the false information.
I would certainly hope so. If nothing else, dramatically expand both the new "right to try" law, and the old FDA "compassionate care/use" law.
How sad is this when you are rooting to go above $2? On MRKR … above $2! ... on NO cytokine release syndrome, above $2? On free and beneficial epitope spreading, above $2.
Interesting info for long time MRKR board members.
OK, Ann Leen, our Chief Scientific Officer, also founded another company we had talk about in the past on this board. That company was ViraCyte. There was discussion here about whether ViraCyte should be rolled into MRKR. Well, ViraCyte was acquired by ElevateBio (a holding company), and they changed the name from Viracyte to AlloVir.
NOW:
AlloVir and Baylor College of Medicine have teamed up to develop T-cell therapies against the novel coronavirus behind the COVID-19 pandemic outbreak. The alliance builds on existing work to create off-the-shelf cell therapies that identify and eliminate specific viruses.
Since setting up shop in 2013, AlloVir (then Viracyte) has built up a body of evidence that it can help people with weakened immune systems cope with viral pathogens. The approach entails exposing donor T cells to cytokines combined with viral fragments, thereby equipping the immune cells to recognize and help eliminate certain pathogens.
The most advanced expression of the approach is Viralym-M, a T-cell therapy designed to take out six viruses that commonly affect immunocompromised patients. Baylor moved that drug into phase 2 in 2014, coming away with data that encouraged AlloVir to plan a late-phase program.
Now, AlloVir and Baylor are applying the same approach to the SARS-CoV-2 virus sweeping across the world. AlloVir is aiming to create an off-the-shelf therapy that is capable of targeting SARS-CoV-2 and potentially similar viruses such as SARS-CoV, MERS-CoV and endemic coronaviruses.
The plan is to position the SARS-CoV-2-specific T cells for use as a monotherapy and incorporate the coronaviruses into ALVR106, a preclinical asset aimed at community-acquired respiratory viruses. In doing so, AlloVir thinks it can improve outcomes in immunocompromised patients who are exposed to SARS-CoV-2 and other viruses with the potential to overwhelm their weakened immune systems.
Neither AlloVir nor Baylor has sketched out a timeline for the COVID-19 program. Other companies, notably those such as Gilead Sciences that repurposed existing drugs, have more advanced assets, but T cells in development at AlloVir could still fill a gap in the treatment landscape. Equally, AlloVir’s interest in coronaviruses other than SARS-CoV-2 means its therapies could still be relevant even if it misses the window in which treatments for the pandemic pathogen are in high demand.
https://www.fiercebiotech.com/biotech/allovir-baylor-ally-to-develop-covid-19-t-cell-therapy
I guess it's just a matter of perspective. As a long time investor (TPIV) and also being a knucklehead who just kept buying more and more as the price dropped, I now have, as many others do, a six figure plus loss at this point.
But, you know, it just doesn't seem to be as important as it was a few weeks ago before covid 19 went exponential on us.
Oh, don't get me wrong, it still sucks, but the big picture just changed recently.
Good Luck and Stay Safe to all.
I think many people are just shell shocked from the bombing in price we have taken, and now, with this damn virus thing happening??
Interest rates at zero, I might get to buy more at $1.20 today. I know, I'm stubborn, but I hope all this buying pays off in the long run.
GOOD LUCK TO EVERYBODY AND STAY SAFE AND HEALTHY.
Well, I was there in October 1987 for that crash. I was there in March 2000 for that tech bubble crash. There for the 2006-2008 real estate bubble crash.
I think this one sucks the most because beside the crash, we still have this damn virus still to deal with.
Yeah, I was "smart" and bought more MRKR at $2.15.
I guess now I'll buy more at $1.50.
What else is there do to?
Here's a question. Wouldn't this be a smart time for the 5 million shorted shares to buy to cover and lock in their profits?
Yeah, I've hit (and had losses on) many singles, doubles and triples.
I was hoping that MRKR would be the home run, which is why I invested such a large percentage of capital towards it.
My other, hoped for home run was PPHM, which BOMBED.
Hello, to give an honest answer, and maybe to add a bit of bigger picture perspective, you are Absolutely Correct in saying that:
#1, MRKR is way down A WHOLE BUNCH and has been heading downward for a good time now, while waiting for positive news.
#2, MRKR has BOTH, gotten down into the $1 to $3 range, AND, has a market cap below the 200/300 million dollar range.
Both of those facts are 100% absolutely correct.
And it was the EXACT same case for other stocks I owned:
ARWR - now worth 3 Billion.
ALNY - now worth 12 Billion
MRTX - now worth 4 Billion